B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
- PMID: 10581077
- DOI: 10.1038/70932
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
Abstract
The B7 family members B7-1 and B7-2 interact with CD28 and constitute an essential T-cell co-stimulatory pathway in the initiation of antigen-specific humoral and cell-mediated immune response. Here, we describe a third member of the B7 family, called B7-H1 that does not bind CD28, cytotoxic T-lymphocyte A4 or ICOS (inducible co-stimulator). Ligation of B7-H1 co-stimulated T-cell responses to polyclonal stimuli and allogeneic antigens, and preferentially stimulated the production of interleukin-10. Interleukin-2, although produced in small amounts, was required for the effect of B7-H1 co-stimulation. Our studies thus define a previously unknown co-stimulatory molecule that may be involved in the negative regulation of cell-mediated immune responses.
Comment in
-
T-cell stimulation: an abundance of B7s.Nat Med. 1999 Dec;5(12):1345-6. doi: 10.1038/70905. Nat Med. 1999. PMID: 10581066 No abstract available.
Similar articles
-
B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.Nat Immunol. 2001 Mar;2(3):269-74. doi: 10.1038/85339. Nat Immunol. 2001. PMID: 11224528
-
T-cell co-stimulation through B7RP-1 and ICOS.Nature. 1999 Dec 16;402(6763):827-32. doi: 10.1038/45582. Nature. 1999. PMID: 10617205
-
T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.Cancer Res. 2001 Mar 1;61(5):1976-82. Cancer Res. 2001. PMID: 11280755
-
[Lymphocyte coreceptors].Med Sci (Paris). 2006 Dec;22(12):1069-74. doi: 10.1051/medsci/200622121069. Med Sci (Paris). 2006. PMID: 17156728 Review. French.
-
The balance of immune responses: costimulation verse coinhibition.J Mol Med (Berl). 2005 Mar;83(3):193-202. doi: 10.1007/s00109-004-0617-1. Epub 2005 Jan 4. J Mol Med (Berl). 2005. PMID: 15630593 Review.
Cited by
-
Innovative theranostic hydrogels for targeted gastrointestinal cancer treatment.J Transl Med. 2024 Oct 27;22(1):970. doi: 10.1186/s12967-024-05749-9. J Transl Med. 2024. PMID: 39465365 Free PMC article. Review.
-
CDKN2A Deletion in Melanoma Excludes T Cell Infiltration by Repressing Chemokine Expression in a Cell Cycle-Dependent Manner.Front Oncol. 2021 Mar 25;11:641077. doi: 10.3389/fonc.2021.641077. eCollection 2021. Front Oncol. 2021. PMID: 33842347 Free PMC article.
-
A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy.Cancer Discov. 2021 Jul;11(7):1700-1715. doi: 10.1158/2159-8290.CD-20-0962. Epub 2021 Mar 3. Cancer Discov. 2021. PMID: 33658301 Free PMC article.
-
Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors.An Bras Dermatol. 2024 May-Jun;99(3):425-432. doi: 10.1016/j.abd.2023.09.003. Epub 2024 Feb 21. An Bras Dermatol. 2024. PMID: 38388337 Free PMC article. Review.
-
Immune checkpoint blockade: a common denominator approach to cancer therapy.Cancer Cell. 2015 Apr 13;27(4):450-61. doi: 10.1016/j.ccell.2015.03.001. Epub 2015 Apr 6. Cancer Cell. 2015. PMID: 25858804 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous